Publications by authors named "Alejandro Balbin"

Claim this Profile
P
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.
Joanne Chiu, Fei Su, Mukta Joshi, Norikazu Masuda, Takashi Ishikawa, O Alejandro Balbin

BMC Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing.
Lauren Fairchild, Jeanne Whalen, Katie D'Aco, Jincheng Wu, Carroll B Gustafson, O Alejandro Balbin

Sci Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer.
Komal Jhaveri, Dejan Juric, Yoon-Sim Yap, Sara Cresta, Rachel M Layman, Alejandro Balbin

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib in Exon 14-Mutated or -Amplified Non-Small-Cell Lung Cancer.
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, O Alejandro Balbin

N Engl J Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.
Enriqueta Felip, Filippo G de Braud, Michela Maur, Herbert H Loong, Alice Tsang Shaw, O Alejandro Balbin

J Thorac Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
Martin van den Bent, Analia Azaro, Filip De Vos, Juan Sepulveda, W K Alfred Yung, O Alejandro Balbin

J Neurooncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Lihui Wang, Yanli He, Weijun Liu, Shengbin Bai, Lei Xiao, O Alejandro Balbin

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Hui Gao, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, O Alejandro Balbin

Nat Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of antisense gene expression in human cancers.
O Alejandro Balbin, Rohit Malik, Saravana M Dhanasekaran, John R Prensner, Xuhong Cao

Genome Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Saravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, Ernest Nadal, Shanker Kalyana-Sundaram

Nat Commun· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
O Alejandro Balbin, John R Prensner, Anirban Sahu, Anastasia Yocum, Sunita Shankar

Nat Commun· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal competition between differentiation programs determines cell fate choice.
Anna Kuchina, Lorena Espinar, Tolga Çağatay, Alejandro O Balbin, Fang Zhang

Mol Syst Biol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized oncology through integrative high-throughput sequencing: a pilot study.
Sameek Roychowdhury, Matthew K Iyer, Dan R Robinson, Robert J Lonigro, Yi-Mi Wu, O Alejandro Balbin

Sci Transl Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.
John R Prensner, Matthew K Iyer, O Alejandro Balbin, Saravana M Dhanasekaran, Qi Cao

Nat Biotechnol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wave function analysis of MHC-peptide interactions.
Constanza Cárdenas, Mateo Obregón, Alejandro Balbín, José Luis Villaveces, Manuel E Patarroyo

J Mol Graph Model· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A theoretical analysis of HLA-DRbeta1*0301-CLIP complex using the first three multipolar moments of the electrostatic field.
Alejandro Balbín, Constanza Cárdenas, José Luis Villaveces, Manuel E Patarroyo

Biochimie· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein folding and evolution are driven by the Maxwell Demon activity of proteins.
Alejandro Balbín, Eugenio Andrade

Acta Biotheor· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele effects in MHC-peptide interactions: a theoretical analysis of HLA-DRbeta1*0101-HA and HLA-DRbeta1*0401-HA complexes.
Constanza Cárdenas, Marysol Ortiz, Alejandro Balbín, José Luis Villaveces, Manuel E Patarroyo

Biochem Biophys Res Commun· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis